A novel supramolecular polymer system, in which the terminal pyrenyl groups of a polyamide intercalate into the chain-folds of a polyimide via electronically-complementary π–π stacking, shows both enhanced mechanical properties relative to those of its individual components and facile healing characteristics as a result of the thermoreversibility of non-covalent interactions.
Heterogeneous photocatalytic systems have the potential to provide green organic synthesis routes for a number of industrially important chemicals. This review presents the latest achievements in this research field and compares them with traditional catalytic systems employed in organic synthesis.
9 September 2010 in Applied Catalysis B: Environment and Energy
The presence of persistent, difficult to degrade pharmaceutical compounds in wastewaters is a significant environmental concern. While heterogeneous photocatalysis can degrade a range of pharmaceutical compounds, as a technology, it is yet to be applied. Current research on heterogeneous photocatalysis for pharmaceutical removal is focused on the development of photocatalytic materials that are both efficient photocatalysts and solar driven as well as materials that combine both adsorption and photocatalysis. The formation of toxic by-products during photocatalytic degradation can be an issue, hence, mechanistic studies to identify reaction pathways and intermediates are important and are discussed in this review. The potential application of photocatalytic systems coupled with other technologies, to achieve complete pollutant removal and avoid toxin formation are also discussed. Given the broad range of properties of these pharmaceutical compounds and their corresponding wastewater matrices, each system needs to be optimised accordingly, with the need for pilot scale studies. Other than end of pipe solutions to reduce the occurrence of pharmaceutical pollutants in the environment, a comprehensive environmental management approach involving strategies such as the reduction of pharmaceutical prescriptions and the introduction of take back schemes are also needed to achieve a reduction of pharmaceutical compounds in the environment.